WESTFIELD CAPITAL MANAGEMENT CO LP - 31 Dec 2024 SCHEDULE 13G/A Report for Ascendis Pharma A/S Common Stock (ASND)

Filing Manager: WESTFIELD CAPITAL MANAGEMENT CO LP
Reporting Manager: Westfield Capital Management Company, L.P.
Security: Ascendis Pharma A/S Common Stock
Symbol: ASND
Shares outstanding: 60.2M shares
Disclosed Ownership: 5.53M shares
Ownership: 9.18%
Form type: SCHEDULE 13G/A
Filing time: 11 Feb 2025, 09:15:25 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Westfield Capital Management Company, L.P.	9.18%	5.53M	3.87M	0	Brandi McMahon	Vice President, Deputy Chief Compliance Officer